Alpharetroviral vectors: from a cancer-causing agent to a useful tool for human gene therapy

Area of Science:

• Molecular Biology
• Virology
• Gene Therapy

Background:

• Integrating retroviral vectors are effective in gene therapy but carry risks of insertional mutagenesis.
• Alpharetroviruses, despite historical association with cancer, exhibit a more random integration pattern, suggesting improved safety over gammaretro- and lentiviruses.

Purpose of the Study:

• To review the history and potential of alpharetroviruses as gene delivery vectors.
• To explain how alpharetroviral vectors can be engineered for enhanced safety and clinical translation.

Main Methods:

• Review of historical data on alpharetroviruses.
• Analysis of vector development strategies for improved safety features.
• Discussion of regulatory compliance for clinical gene therapy.

Main Results:

• Alpharetroviruses can be engineered into advanced gene delivery tools.
• Development focuses on enhancing safety features to mitigate risks associated with gene therapy vectors.
• Alpharetroviral vectors show promise for future gene therapy applications.

Conclusions:

• Alpharetroviral vectors represent a promising advancement in gene therapy vector technology.
• Their development aligns with regulatory requirements for clinical use.
• This review bridges the gap from alpharetrovirus discovery to their clinical potential.